Instil Bio, Inc.

Healthcare

NASDAQ:TIL · NASDAQ Global Select

Market Cap $50.86M Beta 1.91 P/E (TTM) -1.1

$7.50 +0.13%

+$0.01 today

52W Low $5.67High $33.83

Vol 0.02M · Avg 0.03M

EPS (TTM) -$6.99Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-74.87%

Period High

$32.24

Period Low

$6.66

Latest

$7.50

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$264.41M

MacroGenics, Inc.

NASDAQ:MGNX

$261.29M

Shattuck Labs, Inc.

NASDAQ:STTK

$234.90M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$213.63M

Surrozen, Inc.

NASDAQ:SRZN

$169.93M

InflaRx N.V.

NASDAQ:IFRX

$131.47M

Oncolytics Biotech Inc.

NASDAQ:ONCY

$94.74M

Pliant Therapeutics, Inc.

NASDAQ:PLRX

$70.90M

Tevogen Bio Holdings Inc.

TVGN

$42.15M

Atossa Therapeutics, Inc.

ATOS

$17.22M

What is the latest TIL filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does TIL have?

Intrinsic Alpha currently shows 20 recent filings for TIL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.